Allovir Inc
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, human herpesvirus 6,… Read more
Allovir Inc (ALVR) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of December 2024: -0.031x
Based on the latest financial reports, Allovir Inc (ALVR) has a cash flow conversion efficiency ratio of -0.031x as of December 2024.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.57 Million) by net assets ($113.31 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Allovir Inc - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Allovir Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Allovir Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Allovir Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Unlimited Travel Group UTG AB (publ)
ST:UTG
|
1.221x |
|
Alba Mineral Resources plc
PINK:ALBAF
|
-0.008x |
|
New Century Logistics (BVI) Limited Ordinary Shares
NASDAQ:NCEW
|
0.782x |
|
Auris Minerals Ltd
AU:AUR
|
-0.016x |
|
Born Inc
PINK:BRRN
|
250.436x |
|
Retractable Technologies Inc
NYSE MKT:RVP
|
-0.016x |
|
Eurotel SA
WAR:ETL
|
0.124x |
|
Seoul Electronics & Telecom Co. Ltd
KQ:027040
|
-0.173x |
Annual Cash Flow Conversion Efficiency for Allovir Inc (2018–2024)
The table below shows the annual cash flow conversion efficiency of Allovir Inc from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $113.31 Million | $-67.70 Million | -0.598x | +30.01% |
| 2023-12-31 | $145.78 Million | $-124.45 Million | -0.854x | -34.93% |
| 2022-12-31 | $224.52 Million | $-142.05 Million | -0.633x | -34.05% |
| 2021-12-31 | $225.27 Million | $-106.32 Million | -0.472x | -174.02% |
| 2020-12-31 | $353.06 Million | $-60.81 Million | -0.172x | -144.01% |
| 2019-12-31 | $-51.50 Million | $-20.16 Million | 0.391x | +716.75% |
| 2018-12-31 | $-30.62 Million | $1.94 Million | -0.063x | -- |